Choose Language
Select a language for news translation.
The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future wher…
A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding h…
Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to tre…
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results …
David Davis, a power plant worker in Aptos, Calif., was prescribed GLP-1 medication to treat obstructive sleep apnea. To approve the prescription, his insuranc…
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers a…
Customers have complained that a telehealth network selling compounded GLP-1s has been ripping them off—even after it had to pay $5 million to clients as part …
Jordi Visser argues Eli Lilly's AI infrastructure, proprietary metabolic data, and GLP-1 drugs could make it the world's largest company within 5 years. Lilly…
Researchers found that approximately 44% of GLP-1 users reported at least one side effect.
GLP-1 medications are sold under several different brand names and treat diabetes, obesity and sleep apnea. The drugs' affect on cancer is in very early stages…
A new drug called apitegromab could help people on obesity jabs avoid unwanted muscle decline that's been linked to flat bums or "Ozempic butt", according to r…
